A long-term efficacy study of Ustekinumab in patients previously treated with TNF inhibitors and with psoriasis and psoriatic Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- 23 Aug 2016 New trial record